Skip to main content
Premium Trial:

Request an Annual Quote

Cellumen to Collaborate with Mayo Foundation on Breast Cancer Patient Stratification

NEW YORK (GenomeWeb News) - Cellumen said today that it will collaborate with the Mayo Foundation for Medical Education and Research to apply the company’s cellular systems biology approach to breast cancer patient stratification.
 
Cellumen said that the goal of the project is to create a breast cancer patient profile test to help improve disease treatment and diagnosis.
 
"We are treating breast tumors as a 'system' within the breast cancer patient," said Cellumen's CEO, Lansing Taylor.
 
The research will involve multiplexing a "combination of breast cancer biomarkers and migratory immune cell biomarkers," Taylor added.
 
Cellumen has ongoing research programs and business activities in patient profiling and in drug discovery and development.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.